Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
WORKING PAPERS
November 13, 2023
Epidemics and pandemics pose a sporadic and sometimes severe threat to human health. How should policymakers prioritize preventing and preparing for such events, relative to other needs? Our simulations suggest that an event having the mortality level of COVID-19 should not be considered a “once in ...
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
POLICY PAPERS
June 20, 2023
This policy paper examines the state of knowledge on investing in the “best buys” of surveillance for pandemic preparedness. We conduct a rapid literature review to assess the state of knowledge on the costs and benefits of investing in four selected types of surveillance for respiratory infections,...
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...